# Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication

> **NCT03897244** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 603 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** High-dose dual therapy (rabeprazole, amoxicillin)
- **DRUG:** Bismuth High-dose dual therapy (rabeprazole, amoxicillin, tripotassium dicitrate bismuthate)
- **DRUG:** Amoxicillin-Metronidazole Bismuth quadruple therapy

## Key facts

- **NCT ID:** NCT03897244
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-30
- **Primary completion:** 2025-02-11
- **Final completion:** 2025-02-17
- **Target enrollment:** 603 (ACTUAL)
- **Last updated:** 2025-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03897244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03897244, "Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03897244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*